Skip to content

Visuo-cognition in patients with idiopathic Parkinson's disease and healthy older adults - Identification of visuo-cognitive domains and correlations with sociodemographic, neuropsychological and clinical parameters

Visuo-cognition in patients with idiopathic Parkinson's disease and healthy older adults - Identification of visuo-cognitive domains and correlations with sociodemographic, neuropsychological and clinical parameters - VC in PD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00017802
Enrollment
200
Registered
2019-10-18
Start date
2019-10-11
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy older adults G20

Interventions

Group 1: Cross-sectional study with patients with Parkinson's disease (Group 1). Group 2: Cross-sectional study with patients with Parkinson's disease (Group 2).

Sponsors

Uniklinik KölnMedizinische Psychologie | Neuropsychologie und Gender Studies & Centrum für Neuropsychologische Diagnostik und Intervention (CeNDI)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria for patients: Inpatient stay in in cooperating hospitals (Beelitz, Kassel, Marl). Diagnosis of idiopathic Parkinson’s disease without cognitive impairment or with mild cognitive impairment. Age: above 50 years. Ability to follow test instructions and to complete questionnaires. Unimpaired or corrected vision and hearing. German as mother tongue or very good language skills. Inclusion criteria for healthy older adults: No neurological or psychiatric disorders affecting the current cognitive status. Ability to follow test instructions and to complete questionnaires. Age: above 50 years. Unimpaired or corrected vision and hearing. German as mother tongue or very good language skills.

Exclusion criteria

Exclusion criteria: Exclusion Criteria for patients: Life-threatening comorbid conditions, acute suicidality, severe cognitive impairment/dementia according Level-I testing (MMSE < 25). Exclusion Criteria for healthy older adults: Neurological or psychiatric disorders affecting the current cognitive status, life-threatening comorbid conditions, acute suicidality, severe cognitive impairment/dementia according Level-I testing (MMSE < 25).

Design outcomes

Primary

MeasureTime frame
Visuo-cognition including the following three subdomains: visuo-perceptual, visuo-spatial and visuo-constructive abilities. Data will be assessed using the follwoing neuropsychological tests: Visual Object and Space Perception Battery, Rey-Osterrieth Complex Figure, Benton's Judgment of Line Orientation, The Executive Clock Drawing Task (Subtest 1 and Subtest 2), Leistungsprüfsystem (Subtest: Spatial Rotation).

Secondary

MeasureTime frame
Sociodemographic data (age, sex, education) Global cognition: Mini Mental Status Examination, Executive functions: : Consortium to Establish a Registry for Alzheimer´s Disease (CERAD+) Trail-Making-Test B, Wechsler Memory Scale-Revised: Digit Span Forward & Backward. Language: CERAD+ Semantc Word Fluency, CERAD+, Phonematic Word Fluency. Memory: CERAD+ Word List Learning and Recall. Attention: CERAD+ Trail-Making-Test A, Stroop-Test. Language: CERAD+ Boston Naming Test. Depression: Geriatric Depression Scale.

Countries

Germany

Contacts

Public ContactHannah Liebermann-Jordanidis

Uniklinik KölnMedizinische Psychologie | Neuropsychologie und Gender Studies &Centrum für Neuropsychologische Diagnostik und Intervention (CeNDI)

hannah.liebermann@uk-koeln.de+49 221 478-32976

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026